Terumo Cardiovascular Group

e-mail usprint

Autotransfusion

Fresenius C.A.T.S (Continuous AutoTransfusion System), the only available continuous flow autotransfusion technology, is distributed exclusively in the U.S. by Terumo Cardiovascular Group.

Information provided on this website is not intended to make claims that the products are safe and effective for any use other than those explicitly described in the Instructions for Use. Clinicians should refer to the Instructions for Use or Owner's Manuals for complete information on the intended use of any product mentioned in this website.

CASE STUDY: Embrace Change or Face Extinction
As perfusion shifts from traditional cardiopulmonary bypass to a more general blood management focus, Al Stammers, CCP, Geisinger Medical Center, has increased his perfusion caseload through autotransfusion and platelet gel.

BEST PRACTICE: STS Blood Conservation Revision 2011
The STS Blood Conservation Guideline Task Force released its new 2011 practice guidelines: 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines.

PROTOCOL: Fresenius C.A.T.S System Plasma Sequestration Protocol
The plasma sequestration protocol and process to help reduce blood and platelet transfusions during CPB at Mission St. Joseph's Hospital in Asheville, NC.

ABSTRACT: Continuous Autotransfusion in a Jehovah's Witness Undergoing Coronary Artery Bypass Grafting. Anesth & Analg. 1999; 89:262. Booke, et al.
The authors reported the set up and use of the Fresenius C.A.T.S system in a case-report with a Jehovah's Witness patient.

ABSTRACT Implementation of the Continuous AutoTransfusion System (C.A.T.S) in Open Abdominal Aortic Aneurysm Repair: An Observational Comparative Cohort Study. Vascular and Endovascular Surgery, Feb-March 2008; Vol. 42, 32-39, Tawfick, W, et al.
In 187 patients, who underwent AAA, the authors found the Fresenius C.A.T.S system reduced the amount of blood transfused, was associated with reduced ICU and hospital stay, and was cost effective.

ABSTRACT: Improved Outcomes during Cardiac Surgery: a Multifactorial Enhancement of Cardiopulmonary Bypass Techniques. JECT 2005; 37:165-172. Trowbridge CC, et al.
In this study of 576 patients, the authors conclude that patients treated with a best-practice care plan that implements multiple changes simultaneously had significantly fewer complications and decreased mortality rates.

ABSTRACT: Levels of Inflammatory Markers in the Blood Processed by Autotransfusion Devices during Cardiac Surgery Associated with Cardiopulmonary Bypass Circuit. Perfusion 2002; 17:117-123. Amand, et al.
This study evaluates the ability of several cell salvage devices to remove white cells. The C.A.T.S System and Haemonetics CS5 devices removed the highest percentage of white cells.